Mymetics Corp Stock Analysis
| MYMX Stock | USD 0.0003 0.00 0.00% |
Mymetics Corp's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. Mymetics Corp's financial risk is the risk to Mymetics Corp stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that Mymetics Corp's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Mymetics Corp is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Mymetics Corp to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Mymetics Corp is said to be less leveraged. If creditors hold a majority of Mymetics Corp's assets, the Company is said to be highly leveraged.
Mymetics Corp is overvalued with Real Value of 2.52E-4 and Hype Value of 3.0E-4. The main objective of Mymetics Corp pink sheet analysis is to determine its intrinsic value, which is an estimate of what Mymetics Corp is worth, separate from its market price. There are two main types of Mymetics Corp's stock analysis: fundamental analysis and technical analysis.
The Mymetics Corp pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Mymetics |
Mymetics Pink Sheet Analysis Notes
About 55.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.02. Mymetics Corp had not issued any dividends in recent years. Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland. Mymetics Corp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.The quote for Mymetics Corp is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Mymetics Corp contact Ronald Kempers at 41 21 653 4535 or learn more at https://www.mymetics.com.Mymetics Corp Investment Alerts
| Mymetics Corp generated a negative expected return over the last 90 days | |
| Mymetics Corp has some characteristics of a very speculative penny stock | |
| Mymetics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Mymetics Corp currently holds 162 K in liabilities. Mymetics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mymetics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Mymetics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mymetics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mymetics to invest in growth at high rates of return. When we think about Mymetics Corp's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3 K. Net Loss for the year was (4.73 M) with loss before overhead, payroll, taxes, and interest of (545 K). | |
| Mymetics Corp currently holds about 350 K in cash with (1.7 M) of positive cash flow from operations. | |
| Roughly 55.0% of the company outstanding shares are owned by corporate insiders |
Mymetics Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.47 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mymetics Corp's market, we take the total number of its shares issued and multiply it by Mymetics Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mymetics Corp, as well as the relationship between them.Mymetics Corp Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Mymetics Corp price series with the more recent values given greater weights.
Mymetics Corp Outstanding Bonds
Mymetics Corp issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mymetics Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mymetics bonds can be classified according to their maturity, which is the date when Mymetics Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MYLAN N V Corp BondUS62854AAP93 | View | |
| MYLAN N V Corp BondUS62854AAN46 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| MYLAN INC 54 Corp BondUS628530BC02 | View | |
| MYLAN INC 455 Corp BondUS628530BK28 | View | |
| MYLAN INC Corp BondUS628530BJ54 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Mymetics Corp Debt to Cash Allocation
Mymetics Corp currently holds 162 K in liabilities. Mymetics Corp has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Mymetics Corp until it has trouble settling it off, either with new capital or with free cash flow. So, Mymetics Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mymetics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mymetics to invest in growth at high rates of return. When we think about Mymetics Corp's use of debt, we should always consider it together with cash and equity.Mymetics Corp Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Mymetics Corp's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Mymetics Corp, which in turn will lower the firm's financial flexibility.Mymetics Corp Corporate Bonds Issued
About Mymetics Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Mymetics Corp prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Mymetics shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Mymetics Corp. By using and applying Mymetics Pink Sheet analysis, traders can create a robust methodology for identifying Mymetics entry and exit points for their positions.
Mymetics Corporation, a vaccine company, engages in the research and development of vaccines for infectious and life disabling diseases in Switzerland. Mymetics Corporation was founded in 1990 and is based in Epalinges, Switzerland. Mymetics Corp operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 8 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Mymetics Corp to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Additional Tools for Mymetics Pink Sheet Analysis
When running Mymetics Corp's price analysis, check to measure Mymetics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mymetics Corp is operating at the current time. Most of Mymetics Corp's value examination focuses on studying past and present price action to predict the probability of Mymetics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mymetics Corp's price. Additionally, you may evaluate how the addition of Mymetics Corp to your portfolios can decrease your overall portfolio volatility.